Characteristic | Hospital admissions | Participants* | |||
---|---|---|---|---|---|
β-blocker dispensed on hospital day 0 or 1 | β-blocker dispensed on hospital day 0 or 1 | ||||
No(N = 173) | Yes(N = 218) | No(N = 158) | Yes(N = 187) | p value | |
COPD, chronic obstructive pulmonary disease. | |||||
*Data shown reflect participants’ first hospital admission for acute myocardial infarction during the study period. | |||||
Mean age (years) | 75 | 75 | 75 | 74 | 0.34 |
Female (%) | 57 | 57 | 58 | 56 | 0.71 |
Race (% African-American) | 50 | 49 | 48 | 49 | 0.83 |
Died in hospital (%) | 27 | 11 | 29 | 11 | <0.0001 |
Chronic heart failure (N (%)) | 106 (61) | 129 (59) | 93 (59) | 101 (54) | 0.32 |
Asthma or COPD (%) | 35 | 23 | 35 | 22 | 0.008 |
Eligible for β-blocker on admission, based on Medicare criteria (N (%)) | 19 (11) | 49 (22) | 19 (12) | 49 (26) | 0.001 |
β-blocker ordered any time during hospitalization(N (%)) | 41 (24) | 218 (100) | 22 | 100 | <0.0001 |
β-blocker ordered at discharge (N (%)) | 23 (13) | 153 (70) | 11 | 70 | <0.0001 |